Sai Sarvaa Biotech Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
as on 10-12-2024
- Paid Up Capital ₹ 2.50 M
as on 10-12-2024
- Company Age 10 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 7.00 M
as on 10-12-2024
- Revenue 1.19%
(FY 2023)
- Profit 54.24%
(FY 2023)
- Ebitda 34.88%
(FY 2023)
- Net Worth 40.67%
(FY 2023)
- Total Assets 8.19%
(FY 2023)
About Sai Sarvaa Biotech
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 2.50 M.
The company has closed loans amounting to ₹7.00 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Elangovan Srinivasan, Chandrasekaran Bakthavatchalam, Vasudevan Sridharan, and Two other members serve as directors at the Company.
- CIN/LLPIN
U24232TN2014PTC097791
- Company No.
097791
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
21 Oct 2014
- Date of AGM
29 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Pondicherry, Pondicherry, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Sai Sarvaa Biotech Private Limited offer?
Sai Sarvaa Biotech Private Limited offers a wide range of products and services, including Anticoagulant and Antiplatelet Drugs, Enoxaparin Injection, Anti Infective Agent, Cefpodoxime Proxetil Oral Suspension, Vitamin Tablets & Capsules, Vitamin D3 Tablets & Capsules.
Who are the key members and board of directors at Sai Sarvaa Biotech?
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Elangovan Srinivasan  | Director | 21-Oct-2014 | Current |
| Chandrasekaran Bakthavatchalam | Director | 21-Oct-2014 | Current |
| Vasudevan Sridharan | Director | 21-Oct-2014 | Current |
| Prabhakar | Director | 21-Oct-2014 | Current |
| Bharathidhasan | Director | 21-Oct-2014 | Current |
Financial Performance of Sai Sarvaa Biotech.
Sai Sarvaa Biotech Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 1.19% increase. The company also saw a substantial improvement in profitability, with a 54.24% increase in profit. The company's net worth Soared by an impressive increase of 40.67%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sai Sarvaa Biotech?
Unlock access to Sai Sarvaa Biotech's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Sai Primus Lifebiotech Private LimitedActive 7 years 9 monthsElangovan Srinivasan is a mutual person
Lifecare Formulations Private LimitedActive 14 years 5 monthsElangovan Srinivasan is a mutual person
Chengam Industrial Solutions LlpActive 13 years 9 monthsChandrasekaran Bakthavatchalam is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Indian Bank Creation Date: 12 Feb 2016 | ₹2.00 M | Satisfied |
Indian Bank Creation Date: 12 Feb 2016 | ₹5.00 M | Satisfied |
How Many Employees Work at Sai Sarvaa Biotech?
Sai Sarvaa Biotech has a workforce of 27 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sai Sarvaa Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sai Sarvaa Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
